| Florida Behavior Associates | |
|
712 S Ocean Shore Blvd Flagler Beach FL 32136-3602 | |
| (386) 227-6485 | |
| (866) 247-1790 |
| Full Name | Florida Behavior Associates |
|---|---|
| Speciality | Behavior Analyst |
| Location | 712 S Ocean Shore Blvd, Flagler Beach, Florida |
| Authorized Official Name and Position | Shawn David Roberts (MANAGING MEMBER) |
| Authorized Official Contact | 3155205200 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Florida Behavior Associates 712 S Ocean Shore Blvd Flagler Beach FL 32136-3602 Ph: (386) 227-6485 | Florida Behavior Associates 712 S Ocean Shore Blvd Flagler Beach FL 32136-3602 Ph: (386) 227-6485 |
| NPI Number | 1982241295 |
|---|---|
| Provider Enumeration Date | 12/05/2019 |
| Last Update Date | 05/09/2024 |
| Certification Date | 05/09/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982241295 | NPI | - | NPPES |
News Archive
A unique and innovative telemedicine project is providing distant nursing home patients with Parkinson's disease access to neurologists at the University of Rochester Medical Center (URMC).A pilot study of the project - the results of which were released this month at the International Congress of Parkinson's Disease and Movement Disorders in Paris - demonstrates that the system can improve the quality of life and motor function of patients.
A Baylor College of Medicine study on the most common form of vertigo illustrates that certain motions, not medications, can eliminate the vestibular problem's disorienting effects.
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer's and rheumatoid arthritis - and identifying new drug targets and therapies - thanks to work by three computational biology research teams from the University of Arizona Health Sciences, University of Pennsylvania and Vanderbilt University.
Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.
› Verified 1 days ago
Mental Health Transformations Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 324 N 2nd St, Flagler Beach, FL 32136 Phone: 386-530-5158 Fax: 386-693-4081 | |
Integrity Behavioral & Coaching Solutions, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2561 Moody Blvd Ste 209, Flagler Beach, FL 32136 Phone: 407-782-5525 |